As we observed increased platinum sensitivity by CHD4 knockdown consistently in multiple ovarian cancer cells derived from HGSC and clear cell carcinoma, it is plausible to consider that CHD4 suppression can be beneficial to the majority of ovarian cancer cases regardless of the subtype or genomic alterations. Here, CHD4 is linked to ovarian cancer.